{"id":"https://openalex.org/W4283364355","doi":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","title":"P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE","display_name":"P1231: ZILOVERTAMAB VEDOTIN (MK-2140) FOR THE TREATMENT OF NON-HODGKIN LYMPHOMA: THE PHASE 1 DOSE ESCALATION AND COHORT EXPANSION WAVELINE-001 STUDY OF AN ANTI-ROR1 ANTIBODY-DRUG CONJUGATE","alternate_titles":[],"publication_year":2022,"publication_date":"2022-06-01","ids":{"openalex":"https://openalex.org/W4283364355","doi":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/9429579"},"language":"en","primary_location":{"id":"doi:10.1097/01.hs9.0000847788.96420.63","doi":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W4283364355"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5027513506","display_name":"M. Wang","orcid":"https://orcid.org/0009-0000-9433-392X","observed_orcids":["https://orcid.org/0009-0000-9433-392X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"M. Wang","raw_affiliation_strings":["MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063781871","display_name":"Matthew Genyeh Mei","orcid":"https://orcid.org/0000-0002-1109-6955","observed_orcids":["https://orcid.org/0000-0002-1109-6955"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]},{"id":"https://openalex.org/I4210110459","display_name":"City of Hope","ror":"https://ror.org/01z1vct10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Mei","raw_affiliation_strings":["City of Hope Cancer Center, Duarte"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope Cancer Center, Duarte","institution_ids":["https://openalex.org/I1301076528","https://openalex.org/I4210110459"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5055100327","display_name":"Paul M. Barr","orcid":"https://orcid.org/0000-0002-9733-401X","observed_orcids":["https://orcid.org/0000-0002-9733-401X"]},"institutions":[{"id":"https://openalex.org/I28792581","display_name":"University of Rochester Medicine","ror":"https://ror.org/00trqv719","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I28792581","https://openalex.org/I5388228"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. M. Barr","raw_affiliation_strings":["University of Rochester Medical Center, Rochester"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Rochester Medical Center, Rochester","institution_ids":["https://openalex.org/I28792581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075229974","display_name":"Jacqueline C. Barrientos","orcid":"https://orcid.org/0000-0001-6018-5535","observed_orcids":["https://orcid.org/0000-0001-6018-5535"]},"institutions":[{"id":"https://openalex.org/I1302444339","display_name":"Northwell Health","ror":"https://ror.org/02bxt4m23","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1302444339"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Barrientos","raw_affiliation_strings":["Northwell Health, Inc., New Hyde Park"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Northwell Health, Inc., New Hyde Park","institution_ids":["https://openalex.org/I1302444339"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043108859","display_name":"S. de Vos","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801403999","display_name":"UCLA Medical Center","ror":"https://ror.org/04vq5kb54","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799798094","https://openalex.org/I2801403999"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. de Vos","raw_affiliation_strings":["UCLA Santa Monica Medical Center, Santa Monica"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"UCLA Santa Monica Medical Center, Santa Monica","institution_ids":["https://openalex.org/I2801403999"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013974745","display_name":"Richard R. Furman","orcid":"https://orcid.org/0000-0003-1677-7626","observed_orcids":["https://orcid.org/0000-0003-1677-7626"]},"institutions":[{"id":"https://openalex.org/I4387153466","display_name":"Weill Cornell Medicine","ror":"https://ror.org/02r109517","country_code":"US","type":"education","lineage":["https://openalex.org/I205783295","https://openalex.org/I4387153466"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Furman","raw_affiliation_strings":["Weill Cornell Medical College, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Weill Cornell Medical College, New York","institution_ids":["https://openalex.org/I4387153466"]}]},{"author_position":"middle","author":{"id":null,"display_name":"K. Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210093417","display_name":"Swedish Medical Center","ror":"https://ror.org/004jktf35","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210093417","https://openalex.org/I94396219"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"K. Patel","raw_affiliation_strings":["Swedish Cancer Institute, Seattle"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Swedish Cancer Institute, Seattle","institution_ids":["https://openalex.org/I4210093417"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080883357","display_name":"Philip A. Thompson","orcid":"https://orcid.org/0000-0003-2086-6031","observed_orcids":["https://orcid.org/0000-0003-2086-6031"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. A. Thompson","raw_affiliation_strings":["MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Choi","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I36258959","display_name":"University of California San Diego","ror":"https://ror.org/0168r3w48","country_code":"US","type":"education","lineage":["https://openalex.org/I36258959"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Choi","raw_affiliation_strings":["University of California San Diego, San Diego"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Diego, San Diego","institution_ids":["https://openalex.org/I36258959"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043655376","display_name":"Avyakta Kallam","orcid":"https://orcid.org/0000-0001-6801-1601","observed_orcids":["https://orcid.org/0000-0001-6801-1601","https://orcid.org/0009-0007-9323-4568"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Kallam","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101458221","display_name":"Ying Zhu","orcid":"https://orcid.org/0000-0002-5799-3870","observed_orcids":["https://orcid.org/0000-0002-5799-3870"]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Y. Zhu","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth","MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005453392","display_name":"Samhita Chakraborty","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Chakraborty","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth","MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038208984","display_name":"Patricia Maria Marinello","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1285764155","display_name":"Merck & Co., Inc., Rahway, NJ, USA (United States)","ror":"https://ror.org/02891sr49","country_code":"US","type":"company","lineage":["https://openalex.org/I1285764155"]},{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"P. Marinello","raw_affiliation_strings":["Merck & Co., Inc., Kenilworth","MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Merck & Co., Inc., Kenilworth","institution_ids":["https://openalex.org/I1285764155"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5003766253","display_name":"Stephen E. F. Spurgeon","orcid":"https://orcid.org/0000-0001-9962-438X","observed_orcids":["https://orcid.org/0000-0001-9962-438X"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]},{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. E. Spurgeon","raw_affiliation_strings":["Oregon Health and Science University, Portland, United States of America","MD Anderson Cancer Center, Houston"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health and Science University, Portland, United States of America","institution_ids":["https://openalex.org/I165690674"]},{"raw_affiliation_string":"MD Anderson Cancer Center, Houston","institution_ids":["https://openalex.org/I1343551460"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":12,"corresponding_author_ids":["https://openalex.org/A5027513506"],"corresponding_institution_ids":["https://openalex.org/I1343551460"],"apc_list":{"value":2480,"currency":"USD","value_usd":2480},"apc_paid":{"value":2480,"currency":"USD","value_usd":2480},"fwci":null,"has_fulltext":true,"cited_by_count":14,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"6","issue":null,"first_page":"1116","last_page":"1117"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9613999724388123,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.02850000001490116,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0031999999191612005,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ror1","display_name":"ROR1","score":0.878000020980835},{"id":"https://openalex.org/keywords/antibody-drug-conjugates","display_name":"antibody-drug conjugates","score":0.9710000157356262},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9549999833106995},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.8119999766349792},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.9070000052452087},{"id":"https://openalex.org/keywords/hematologic-malignancies","display_name":"hematologic malignancies","score":0.7540000081062317},{"id":"https://openalex.org/keywords/monomethyl-auristatin-e","display_name":"monomethyl auristatin E","score":0.8640000224113464},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.5910000205039978},{"id":"https://openalex.org/keywords/relapsed-refractory-disease","display_name":"relapsed/refractory disease","score":0.753000020980835}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8256146907806396},{"id":"https://openalex.org/C2777058707","wikidata":"https://www.wikidata.org/wiki/Q123251","display_name":"Follicular lymphoma","level":3,"score":0.6325337886810303},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.553926408290863},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.49331632256507874},{"id":"https://openalex.org/C2910423619","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Lymphoplasmacytic Lymphoma","level":4,"score":0.4692901074886322},{"id":"https://openalex.org/C2777525834","wikidata":"https://www.wikidata.org/wiki/Q268713","display_name":"Mantle cell lymphoma","level":3,"score":0.44450944662094116},{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.43765944242477417},{"id":"https://openalex.org/C2777325958","wikidata":"https://www.wikidata.org/wiki/Q1069596","display_name":"Antibody-drug conjugate","level":4,"score":0.4318375885486603},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4237297773361206},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.33859783411026},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.279236376285553},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.2191876471042633},{"id":"https://openalex.org/C2781038049","wikidata":"https://www.wikidata.org/wiki/Q1778287","display_name":"Waldenstrom macroglobulinemia","level":3,"score":0.19212913513183594},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.1718306541442871},{"id":"https://openalex.org/C70905583","wikidata":"https://www.wikidata.org/wiki/Q3648608","display_name":"CD30","level":3,"score":0.09940463304519653}],"mesh":[],"locations_count":3,"locations":[{"id":"doi:10.1097/01.hs9.0000847788.96420.63","doi":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:9429579","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9429579/","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC9429579/pdf/","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Hemasphere","raw_type":"Text"},{"id":"pmh:oai:doaj.org/article:7ad551f20ba9456aa278111a3024dbac","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7ad551f20ba9456aa278111a3024dbac","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"HemaSphere, Vol 6, Pp 1116-1117 (2022)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1097/01.hs9.0000847788.96420.63","doi":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","is_oa":true,"landing_page_url":"https://doi.org/10.1097/01.hs9.0000847788.96420.63","pdf_url":null,"source":{"id":"https://openalex.org/S4210211592","display_name":"HemaSphere","issn_l":"2572-9241","issn":["2572-9241"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-2","norway-1","oarl","poland-20","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310318547","host_organization_name":"Wolters Kluwer","host_organization_lineage":["https://openalex.org/P4310318547"],"host_organization_lineage_names":["Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"HemaSphere","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9789000153541565}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4283364355.pdf","grobid_xml":"https://content.openalex.org/works/W4283364355.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3212412933","https://openalex.org/W4310107141","https://openalex.org/W4200570830","https://openalex.org/W4386072686","https://openalex.org/W4379341612","https://openalex.org/W4389242904","https://openalex.org/W4380077843","https://openalex.org/W4385704543","https://openalex.org/W4379346448","https://openalex.org/W4409822220"],"abstract_inverted_index":{"Background:":[0],"The":[1,43,333],"receptor":[2,6],"tyrosine":[3],"kinase-like":[4],"orphan":[5],"1":[7,63,159,175,240,253,337,496],"(ROR1)":[8],"is":[9,20,330,547],"a":[10,25,30,374,400,501,532,537,550],"transmembrane":[11],"protein":[12],"overexpressed":[13],"in":[14,48,55,79,238,251,325,349,427,479,494,558],"hematological":[15],"malignancies.":[16,85],"Zilovertamab":[17],"vedotin":[18,47,75,145,546],"(MK-2140)":[19],"an":[21,93,199,293],"antibody-drug":[22],"conjugate":[23],"comprising":[24],"humanized":[26],"IgG1":[27],"monoclonal":[28],"antibody,":[29],"proteolytically":[31],"cleavable":[32],"linker,":[33],"and":[34,71,98,138,176,193,227,298,311,328,367,469,473,509,534,554],"the":[35,213,272,394,428,448,522,541],"antimicrotubule":[36],"cytotoxic":[37],"agent":[38],"monomethyl":[39],"auristatin":[40],"E":[41],"(MMAE).":[42],"cytotoxicity":[44],"of":[45,73,96,101,150,212,229,246,271,275,287,296,404],"zilovertamab":[46,74,144,545],"hematologic":[49,84],"cell":[50,121],"lines":[51],"has":[52],"been":[53],"demonstrated":[54],"preclinical":[56],"studies.":[57],"Aims:":[58],"This":[59],"first":[60],"human":[61],"phase":[62],"dose":[64,216,255],"escalation":[65],"study,":[66],"WAVELINE-001":[67],"(NCT03833180),":[68],"evaluated":[69],"safety":[70,552],"efficacy":[72],"at":[76,147],"various":[77],"doses":[78,149],"patients":[80],"(pts)":[81],"with":[82,92,235,303,309,316,423,467,497,544,549,560],"relapsed/refractory":[83,561],"Methods:":[86],"Eligible":[87],"pts":[88,234,248,288,319,351,371,422,426,446,466,493,517,530,559],"aged":[89],"\u226518":[90],"years":[91],"ECOG":[94,294],"PS":[95,295],"0-2":[97],"histological":[99],"diagnosis":[100],"chronic":[102],"lymphocytic":[103,105],"leukemia/small":[104],"leukemia,":[106,112,115],"lymphoplasmacytic":[107],"lymphoma/Waldenstr\u00f6m":[108],"macroglobulinemia,":[109],"acute":[110,113,384],"lymphoid":[111],"myeloid":[114],"or":[116,181,266],"non-Hodgkin":[117],"lymphoma":[118,122,132],"(NHL;":[119],"mantle":[120],"[MCL],":[123],"follicular":[124],"lymphoma,":[125,128,137],"marginal":[126],"zone":[127],"diffuse":[129],"large":[130],"B-cell":[131],"[DLBCL],":[133],"Richter":[134],"transformation,":[135],"Burkitt":[136],"T-cell-NHL)":[139],"were":[140,249,289,301,307,314],"enrolled.":[141],"Pts":[142],"received":[143,321,519],"intravenously":[146],"starting":[148],"0.50":[151],"mg/kg":[152,167,183],"(up":[153],"to":[154,170,186,340,383],"2.5":[155,342],"mg/kg)":[156,172,188,269],"on":[157,173,189],"day":[158,174],"every":[160],"3":[161,202,204,329],"weeks":[162],"(Q3W)":[163],"(Schedule":[164,179,196],"1),":[165],"1.0":[166,182],"(planned":[168,184],"up":[169,185],"2.25":[171,187,264],"8":[177],"Q3W":[178],"2),":[180],"days":[190],"1,":[191,398],"8,":[192],"15":[194,318],"Q4W":[195],"3)":[197],"using":[198],"accelerated":[200],"plus":[201],"+":[203],"dose-escalation":[205],"design.":[206],"Primary":[207],"end":[208,219],"point":[209],"was":[210,281,338,389,410,436,456,485,524],"determination":[211],"maximum":[214],"tolerated":[215],"(MTD).":[217],"Secondary":[218],"points":[220],"included":[221],"safety,":[222],"objective":[223],"response":[224,230],"rate":[225],"(ORR),":[226],"duration":[228],"(DOR).":[231],"Data":[232],"for":[233,335,507,514],"NHL":[236,429,449,498],"enrolled":[237,250],"Schedule":[239,252,336,397,495],"are":[241],"presented.":[242],"Results:":[243],"A":[244],"total":[245],"51":[247],"(starting":[254],"0.5":[256],"[n=1],":[257],"1.00":[258],"[n=3],":[259,261,263],"1.50":[260],"2.00":[262],"[n=11],":[265],"2.50":[267],"[n=30]":[268],"as":[270],"data":[273],"cutoff":[274],"May":[276],"18,":[277],"2021.":[278],"Median":[279,483],"age":[280],"70":[282],"(range,":[283,406,488,505,512],"44-91)":[284],"years,":[285],"54.9%":[286],"male,":[290],"49.0%":[291],"had":[292,432,452,476,531,536],"0,":[297],"41/51":[299],"(80%)":[300],"diagnosed":[302,308,315],"NHL;":[304],"13/51":[305],"(25.5%)":[306],"DLBCL":[310,433,468,508],"17/51":[312],"(33.3%)":[313],"MCL.":[317,515],"(29.4%)":[320],"prior":[322,520],"CAR-T/CAR-NK.":[323],"Enrollment":[324],"Schedules":[326],"2":[327,529],"currently":[331],"ongoing.":[332],"MTD":[334],"determined":[339],"be":[341],"mg/kg.":[343],"Treatment-related":[344],"adverse":[345],"events":[346],"(AEs)":[347],"occurred":[348],"37":[350],"(72.5%),":[352],"most":[353],"commonly":[354],"(\u226520%)":[355],"peripheral":[356],"neuropathy":[357],"(47.0%),":[358],"fatigue":[359],"(37.3%),":[360],"neutrophil":[361],"count":[362],"decrease":[363,478],"(31.4%),":[364],"nausea":[365],"(27.5%),":[366],"diarrhea":[368],"(21.6%);":[369],"24":[370],"(47.1%)":[372],"experienced":[373],"grade":[375],"\u22653":[376],"treatment-related":[377,392],"AE.":[378],"One":[379],"pt":[380],"died":[381],"due":[382],"respiratory":[385],"failure;":[386],"however,":[387],"it":[388],"not":[390],"considered":[391],"by":[393],"investigator.":[395],"For":[396,425,445,465,516],"after":[399],"median":[401],"(range)":[402],"follow-up":[403],"17.3":[405],"1.2-25.8)":[407],"mo,":[408],"ORR":[409,435,455,523],"36.6%":[411],"(15/41":[412],"[95%":[413],"CI,":[414,439,459,527],"22.1%-53.1%];":[415],"5":[416],"CR;":[417],"10":[418,510],"PR)":[419],"among":[420,491],"all":[421,492],"NHL.":[424,562],"group":[430,450],"who":[431,451,499,518],"(n=13),":[434],"38.5%":[437],"(95%":[438,458,526],"13.9%-68.4%;":[440],"CR":[441,461,533],"3;":[442],"PR":[443,463],"2).":[444],"from":[447],"MCL":[453],"(n=17),":[454],"52.9%":[457],"27.8%-77.0%;":[460],"2;":[462],"7).":[464],"MCL,":[470],"9/13":[471],"(69.0%)":[472],"9/17":[474],"(53%)":[475],"any":[477],"target":[480],"lesions,":[481],"respectively.":[482],"DOR":[484],"7.8":[486],"mo":[487,504,511],"2.1-17.6+":[489],"mo)":[490],"achieved":[500],"response;":[502],"4.6":[503],"2.9-17.6)":[506],"2.1-15.7)":[513],"CAR-T/CAR-NK,":[521],"40.0%":[525],"16.3%-67.6%);":[528],"4":[535],"PR.":[538],"Summary/Conclusion:":[539],"Targeting":[540],"ROR1":[542],"pathway":[543],"associated":[548],"tolerable":[551],"profile":[553],"promising":[555],"antitumor":[556],"activity":[557]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W4283364355","counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2022-06-25T00:00:00"}
